Theranostic Project Collaboration

These are projects conducted in collaboration between academia and industry for the development, implementation, or measurement of theranostic technologies used in the field of nuclear medicine.

Project collaborations can be aimed at early diagnosis of diseases, personalization of treatment methods, and monitoring patients’ responses to treatment.

These projects require teams with expertise and multidisciplinary working capabilities, combining academic infrastructure and industrial experience.

EDH is pioneering an innovative culture in the theranostic field.

The introduction of radiopharmaceuticals such as Actinium-225, Terbium-161, and Phosphorus-32 for the first time to the physicians and patients in the region with a personalized treatment approach has been made possible by EDH’s multidisciplinary treatment philosophy, experience, and expertise in the field.

We are pleased to collaborate in the conduct of new theranostic development projects as well as the integration of your nuclear medicine infrastructure with international projects, thanks to our extensive knowledge and experience in the radiopharmacy field.